Roche’s Multiple Sclerosis Forums Archive

In parallel to the 2017 and 2018 European Academy of Neurology (EAN) congresses, Roche hosted a series of live webcasts: “Shifting mindsets in MS: the need for policy change and better outcomes” and “Maintaining independence in progressive MS”.

Find out more information and watch both panel discussions on-demand here.


Maintaining independence in progressive multiple sclerosis

The progressive nature of multiple sclerosis (MS) can significantly impact the day-to-day lives and independence of people living with MS and their caregivers.

This MS Forum aimed to explore the impact of progressive MS on the health and wellbeing of both people with the disease and their caregivers as well as the importance of maintaining independence when living with this disease.

Listen to Amanda Montague, Vice-President of Education and Healthcare Relations at MSAA, Alexandre Silva, vice-president of SPEM and living with relapsing MS and Tony Cardis, who lives with primary progressive MS, facilitated by Jane Symons, former Health Editor of the Sun, discuss the importance and inherent value of living independently with MS.


Shifting mindsets in MS: the need for policy change and better outcomes

MS is a serious and disabling chronic condition that significantly impacts people with MS, their ability to stay in work and as such, the overall productivity of a country. There is an urgent need to improve diagnostic and monitoring criteria to ensure better outcomes.

The London School of Economics International MultiPlE Sclerosis Study (IMPrESS) explored the significant impact of MS on the health and wellbeing of people with the disease and their caregivers, as well as expanding on previous knowledge of the socioeconomic burden of MS.

Listen to Dr. Panos Kanavos, Professor Gavin Giovannoni, Professor Tjalf Ziemssen, Joan Jordan and George Pepper who live with MS, discuss the findings of the IMPrESS report, the current challenges related to the effective management of MS and how these challenges impact the health and wellbeing of both people with MS and their caregivers.


Meeting organised and sponsored by F. Hoffmann-La Roche Ltd